<DOC>
	<DOCNO>NCT01294566</DOCNO>
	<brief_summary>This study First Time In Human study motilin receptor agonist , GSK1322888 . GSK1322888 potent selective small molecule motilin receptor agonist , distinct motilide compound structure . The aim study assess safety , tolerance , pharmacokinetics single oral dos GSK1322888 identify well-tolerated safe dose accelerate gastric empty 13C stable isotope-labeled test meal healthy volunteer . The study include assessment ECGs , vital sign , safety laboratory sampling , adverse event , pharmacokinetics , 13C-Octanoic Acid Breath Test measure gastric emptying .</brief_summary>
	<brief_title>FTIH Evaluate Safety , Tolerability , Pharmacokinetics Single Oral Doses GSK1322888 Healthy Caucasian Japanese Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Gastroparesis</mesh_term>
	<criteria>AST , ALT , alkaline phosphatase bilirubin &lt; =1.5xULN ( isolated bilirubin &gt; 1.5xULN acceptable bilirubin fractionate direct bilirubin &lt; 35 % ) . Healthy determine responsible experienced physician Male female 18 ( 20 Japanese ) 65 year age inclusive Male subject female partner childbearing potential must agree use one contraception method Body weight &gt; = 50 kg BMI within range 18.5 29.9 kg/m2 ( inclusive ) . Capable give write informed consent Average QTc , QTcB QTcF &lt; 430 msec . For Japanese subject Japanese ancestry define born Japan , four ethnic Japanese grandparent , hold Japanese passport identity paper able speak Japanese . Hepatitis B Hepatitis C positive Current chronic history liver disease , know hepatic biliary abnormality ( exception Gilbert 's syndrome asymptomatic gallstone ) . A positive prestudy drug/alcohol screen . HIV positive History regular alcohol consumption within 6 month study Exposure four new chemical entity within 12 month prior first dose day . Use prescription nonprescription drug , include vitamin , herbal dietary supplement ( include St John 's Wort ) within 7 day ( 14 day drug potential enzyme inducer ) prior first dose study medication History sensitivity study medication , component thereof Where participation study would result donation blood blood product excess 500 mL within 56 day period . Pregnant female Unwillingness inability follow procedure outline protocol . Subject mentally legally incapacitate . Regular use tobacco nicotinecontaining product within 6 month prior screen . Consumption red wine , seville orange , grapefruit grapefruit juice and/or pummelo , exotic citrus fruit , grapefruit hybrid fruit juices 7 day prior first dose study medication . Subjects screen subject exhibit rapid gastric empty rate ( tÂ½b &lt; 75 min ) exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>safety</keyword>
	<keyword>motilin agonist</keyword>
	<keyword>single dose</keyword>
	<keyword>ascend dose</keyword>
	<keyword>GSK1322888</keyword>
	<keyword>migrate motor complex</keyword>
	<keyword>tolerability</keyword>
	<keyword>FTIH</keyword>
	<keyword>gastric empty</keyword>
</DOC>